Hepatology · Infectious disease
Hepatitis B treatment in China
China has world-class hepatology infrastructure and the most affordable access to modern HBV antivirals globally. Tenofovir alafenamide (TAF) is USD 15–30/month vs USD 1,400+ in the US.
Overview
Chronic hepatitis B (CHB) affects approximately 296 million people globally per WHO estimates and remains one of the leading causes of cirrhosis and hepatocellular carcinoma. Modern nucleos(t)ide analogue therapy — entecavir, tenofovir disoproxil (TDF), and tenofovir alafenamide (TAF) — suppresses HBV DNA to undetectable in over 95% of treatment-naive patients, dramatically reducing long-term liver and cancer risk.
The barrier outside Class A Chinese care is rarely the medicine itself. It is the price. China has the most economical access to modern HBV antiviral therapy globally, with structured hepatology infrastructure to support both initial workup and long-term monitoring.
Common symptoms
- Most chronic HBV is asymptomatic — the majority of carriers are diagnosed incidentally
- Fatigue, malaise, low-grade abdominal discomfort in some patients
- Acute hepatitis B can present with jaundice, dark urine, anorexia, nausea
- Advanced disease: ascites, oedema, GI bleeding, hepatic encephalopathy (cirrhosis-related)
Risk factors
- Born in HBV-endemic country (China, SE Asia, Africa, parts of Eastern Europe)
- Parent born in an HBV-endemic region (vertical transmission)
- Multiple sexual partners or sex with HBV-positive partner
- IV drug use (any frequency, any time)
- Healthcare or laboratory worker with blood exposure
- Haemodialysis, immunosuppression, HIV-positive
- Blood products received before screening was standard in your country
Standard diagnostic workup
Cost band at Class A international department: USD 200–340 all-in.
- HBsAg + anti-HBs + anti-HBc (initial 3-marker panel)
- If HBsAg positive: HBeAg + anti-HBe, HBV DNA quantitation
- ALT, AST, GGT, complete metabolic panel, alpha-fetoprotein (HCC screening)
- Abdominal ultrasound + FibroScan transient elastography for fibrosis staging
- Hepatology consultation with structured treatment plan
Treatment options
Tenofovir alafenamide (TAF / Vemlidy)
Modern oral antiviral with excellent bone and renal safety profile. China price: USD 15–30/month vs USD 1,400–1,800/month US.
Tenofovir disoproxil (TDF, generic)
Long-established first-line option. Generic available widely. China price: USD 5–15/month.
Entecavir (generic)
Alternative first-line nucleoside analogue. China price: USD 8–20/month.
Pegylated interferon alfa-2a
Finite 48-week course; appropriate for selected HBeAg-positive patients with elevated ALT and low HBV DNA. Higher rate of HBsAg loss but more side effects than oral antivirals.
Liver transplant
Indicated for decompensated cirrhosis or HCC within criteria. Tianjin First Center, Renji, and major Beijing centres run high-volume programmes.
Frequently asked
- Should I get tested for hepatitis B?
- Most international guidelines recommend at least one-time HBV testing for adults. Higher-risk groups (people born in HBV-endemic countries, family history, IV drug use, multiple sexual partners) should be tested without delay. Take our HBV risk screener for a structured 3-minute risk stratification.
- How much does HBV testing and workup cost in China?
- The standard 3-marker panel (HBsAg + anti-HBs + anti-HBc) is USD 15–30 at any Class A international department. Comprehensive workup with HBV DNA, FibroScan, ultrasound, and hepatology consultation is USD 200–340 all-in.
- Why is tenofovir so much cheaper in China?
- China's centralised pharmaceutical procurement, generic competition, and inclusion on the National Reimbursement Drug List combine to make antivirals affordable. The TAF molecule has been on the NRDL with negotiated pricing that flows through to international department fees.
- Can I get long-term refills shipped after my initial visit?
- Initial prescription requires in-person evaluation at a Class A hepatology department. Subsequent refills can typically be coordinated via telehealth with the prescribing physician, with licensed-channel shipment available in many cases. Confirm details with your coordinator at the initial visit.
- What's the difference between TAF and TDF?
- Both are tenofovir prodrugs with similar efficacy. TAF (alafenamide) achieves higher intracellular drug concentration at lower plasma levels, with favourable bone and renal safety. TDF (disoproxil) has decades of follow-up data and is significantly cheaper. The choice depends on bone density, renal function, and cost considerations.
Hepatitis B risk screener
CDC-aligned risk-factor screener. Identifies whether HBV testing (HBsAg + anti-HBs + anti-HBc) is recommended.
Take the Hepatitis B risk screenerRelated medication
Medication detail →Related specialty
Hepatology · Infectious disease hub →Talk to a senior physician
Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.
Book free consult